Analyst
Taylor Chartier is an analyst at Valley Capital Partners evaluating AI and Midwest deal flow.
In addition, Taylor is the CEO of Modicus Prime, helping pharmaceutical companies apply machine learning and artificial intelligence for multivariate modeling to optimize pharmaceutical production, perform root cause analysis, and generate leads that can result in safer and more efficient production of drugs for patient care. Taylor’s education consists of a 5-year accelerated bachelors and masters program in chemical engineering at the University of Rochester, NY, and was most recently pursuing a PhD in applied AI with wearables research for Parkinson’s patients at the University of Luxembourg.